Skip to content

Clinical study of pestle acupuncture in treating chronic lumbago and lower limb pain and numbness of lumbar disc herniation

Clinical study of pestle acupuncture in treating chronic lumbago and lower limb pain and numbness of lumbar disc herniation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078683
Enrollment
Unknown
Registered
2023-12-15
Start date
2023-12-15
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation

Interventions

Pestle acupuncture group:None
Electroacupuncture group:None

Sponsors

Shanghai Sixth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? The case is from patients who were hospitalized for lumbar disc herniation in the Acupuncture and Push Injury Department of the Shanghai Sixth People's Hospital from January 1, 2018 to August 31, 2022; ? CT or MRI examination shows changes in lumbar disc herniation; ? Symptoms such as lower back pain or lower back pain accompanied by numbness, traction and soreness in one or both lower limbs, or recurrent lower limb symptoms for more than 1 year; ? Between the ages of 18 and 65; ? Not simultaneously using drugs or food that affect the efficacy of the treatment methods and detection indicators involved in this study within one month prior to hospitalization; ? The required main medical records are complete and can be followed up; Patients who have been hospitalized or visited multiple times will be included in their initial medical records from January 1, 2018 to August 31, 2022.

Exclusion criteria

Exclusion criteria: ? Lumbar disc herniation combined with cauda equina syndrome and conus medullaris syndrome; ? History of surgical treatment for intervertebral disc herniation in the past; ? Accompanied by spinal tuberculosis, compression fractures, spinal tumors, grade II or above lumbar spondylolisthesis, ankylosing spondylitis, severe osteoporosis, etc; ? Individuals with systemic collagen immune diseases and other acute and chronic infections who may be affected by the use of glucocorticoids or other medications that may affect the outcome judgment; ? Simultaneously applying drugs or foods that affect the efficacy of the treatment methods and detection indicators involved in this study; ? Those with severe diseases of the heart, brain, liver, kidney, and hematopoietic system; ? Patients with mental illness or other serious illnesses; ? Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Clinical efficiency;

Secondary

MeasureTime frame
VAS scores;JOA scores;Muscle state determination;Measurement of nerve conduction velocity;

Countries

China

Contacts

Public ContactZhang Jingzhi

Shanghai Sixth People’s Hospital

zjzjane16@126.com+86 136 3668 5377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026